How many clinical trials has Universitätsklinikum Hamburg-Eppendorf sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Universitätsklinikum Hamburg-Eppendorf, of which 11 are actively recruiting participants. These trials cover conditions including This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers, Atrial Fibrillation, Childhood Brain Tumor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Universitätsklinikum Hamburg-Eppendorf research focus on?
Universitätsklinikum Hamburg-Eppendorf clinical trials span This Study Aims to Evaluate the Safety Profile and Tissue Changes After Biostimulatory Treatments to the Face in Healthy Volunteers, Atrial Fibrillation, Childhood Brain Tumor, Acute Ischemic Stroke, Mitral Regurgitation, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Universitätsklinikum Hamburg-Eppendorf clinical trial?
To participate in a Universitätsklinikum Hamburg-Eppendorf trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Universitätsklinikum Hamburg-Eppendorf trials with current recruitment status updated daily.